SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15530472
Source:
http://linkedlifedata.com/resource/pubmed/id/15530472
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0040649
,
umls-concept:C0132512
,
umls-concept:C0227525
,
umls-concept:C0521447
pubmed:issue
1-2
pubmed:dateCreated
2004-11-8
pubmed:abstractText
Recent findings suggest that some dihydropyridine-type calcium channel blockers, widely used as anti-hypertensive drugs, have direct anti-atherogenic action through their antioxidant properties.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/1302422
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen
,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B
,
http://linkedlifedata.com/resource/pubmed/chemical/Nifedipine
,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1
,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor RelA
,
http://linkedlifedata.com/resource/pubmed/chemical/nilvadipine
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0009-8981
pubmed:author
pubmed-author:AsaiMasatoM
,
pubmed-author:IwasakiYasumasaY
,
pubmed-author:KambayashiMachikoM
,
pubmed-author:NakashimaNobuoN
,
pubmed-author:NigawaraTakeshiT
,
pubmed-author:OisoYutakaY
,
pubmed-author:YoshidaMasanoriM
pubmed:issnType
Print
pubmed:volume
350
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
151-7
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:15530472-Arteriosclerosis
,
pubmed-meshheading:15530472-Base Sequence
,
pubmed-meshheading:15530472-Electrophoresis
,
pubmed-meshheading:15530472-Fibrinogen
,
pubmed-meshheading:15530472-Gene Expression
,
pubmed-meshheading:15530472-Hepatocytes
,
pubmed-meshheading:15530472-Humans
,
pubmed-meshheading:15530472-NF-kappa B
,
pubmed-meshheading:15530472-Nifedipine
,
pubmed-meshheading:15530472-Plasminogen Activator Inhibitor 1
,
pubmed-meshheading:15530472-Time Factors
,
pubmed-meshheading:15530472-Transcription, Genetic
,
pubmed-meshheading:15530472-Transcription Factor RelA
pubmed:year
2004
pubmed:articleTitle
Nilvadipine inhibits nuclear factor-kappaB-dependent transcription in hepatic cells.
pubmed:affiliation
Department of Clinical Pathophysiology, Nagoya University Graduate School of Medicine and Hospital, Nagoya 466-8550, Japan. iwasaki@med.kochi-u.ac.jp
pubmed:publicationType
Journal Article